Nomination of vaccine skeptic Robert F. Kennedy Jr. for Health and Human Services leads to vaccine stock prices dropping.
President-elect Trump has nominated Robert F. Kennedy Jr., a known vaccine skeptic, to lead the Department of Health and Human Services. This decision has led to a decline in stock prices for vaccine makers such as Moderna, Pfizer, and Novavax. Health experts worry that Kennedy’s anti-vaccine stance could discourage vaccinations and negatively impact public health and company profits.
5 months ago
326 Articles
Articles
Further Reading
You have 4 free stories remaining this month. Subscribe anytime for unlimited access.